Article Information
History
- April 10, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Austin Nam1,*,
- Raphael Ximenes1,
- Man Wah Yeung1,
- Sharmistha Mishra2,3,4,5,
- Jianhong Wu6,
- Matthew Tunis1 and
- Beate Sander4,7,8,9
- 1Centre for Immunization Readiness, Public Health Agency of Canada, Ottawa, Ontario, Canada
- 2Department of Medicine, University of Toronto, Toronto, Ontario, Canada
- 3Division of Infectious Disease, Unity Health Toronto, Toronto, Ontario, Canada
- 4Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada
- 5Institute of Medical Sciences, University of Toronto, Toronto, Ontario, Canada
- 6Department of Mathematics and Statistics, York University, Toronto, Ontario, Canada
- 7University Health Network, Toronto, Ontario, Canada
- 8Public Health Ontario, Toronto, Ontario, Canada
- 9Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada
- ↵*Corresponding author:
Austin Nam, Centre for Immunization Readiness, Public Health Agency of Canada, Ottawa, Ontario, Canada, austin.nam{at}canada.ca
Posted April 10, 2021.
Modelling the impact of extending dose intervals for COVID-19 vaccines in Canada
